|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 10 (May 15), 1999:
pp. 3531-3539
Human Monocytes Constitutively Express Membrane-Bound, Biologically
Active, and Interferon- -Upregulated Interleukin-15
Tiziana Musso,
Liliana Calosso,
Mario Zucca,
Maura Millesimo,
Daniela Ravarino,
Mirella Giovarelli,
Fabio Malavasi,
Alessandro Negro Ponzi,
Ralf Paus, and
Silvia Bulfone-Paus
From the Department of Public Health and Microbiology, Postgraduate
School of Clinical Pathology, Department of Genetics, Biology and
Medical Chemistry, and Department of Clinical and Biological Sciences,
University of Turin, Turin, Italy; the Institute of Biology and
Genetics, University of Ancona, Ancona, Italy; the Department of
Dermatology, Charité, Humboldt University, Berlin, Germany; and
the Institute for Immunology, University Hospital Benjamin Franklin,
Free University Berlin, Berlin, Germany.
Interleukin-15 (IL-15) is a potent regulator of T-, B-, and natural
killer cell proliferation and displays unusually tight controls of
secretion. Even though IL-15 mRNA is constitutively expressed in
monocytes/macrophages and is upregulated by a variety of stimuli,
evidence for IL-15 cytokine secretion is only found exceptionally, eg,
conditions of pathological, chronic inflammation. This raises the
possibility that monocytes express membrane-bound IL-15 rather than
secrete it. The current study explores this hypothesis. We demonstrate
here that biologically active IL-15 is indeed detectable in a
constitutively expressed, membrane-bound form on normal human
monocytes, as well as on monocytic cell lines (MONO-MAC-6, THP-1, and
U937), but not on human T or B cells (MT4, M9, C5966, JURKAT, DAUDI,
RAJI, and Epstein-Barr virus-immortalized B-cell clones). Furthermore,
cell surface-bound IL-15 is upregulated upon interferon-
stimulation. Interestingly, monocyte/macrophage inhibitory cytokines
such as IL-4 and IL-13 fail to downregulate both constitutive and
induced cell-surface expression of IL-15. Membrane-bound IL-15 does not
elute with acetate buffer or trypsin treatment, suggesting that it is
an integral membrane protein and that it is not associated with the
IL-15 receptor complex. Finally, membrane-bound IL-15 stimulates T
lymphocytes to proliferate in vitro, indicating that it is biologically
active. These findings enlist IL-15 in the fairly small family of
cytokines for which the presence of a biologically active
membrane-bound form has been demonstrated (eg, IL-1, tumor necrosis
factor- , and IL-10) and invites the speculation that most of the
biological effects of IL-15 under physiological conditions are exerted
by the cell surface-bound form.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. H. McIntire, K. G. Ganacias, and J. S. Hunt
Programming of Human Monocytes by the Uteroplacental Environment
Reproductive Sciences,
May 1, 2008;
15(5):
437 - 447.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. de Totero, R. Meazza, M. Capaia, M. Fabbi, B. Azzarone, E. Balleari, M. Gobbi, G. Cutrona, M. Ferrarini, and S. Ferrini
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways
Blood,
January 15, 2008;
111(2):
517 - 524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Wang, J. W. Holland, A. Carrington, J. Zou, and C. J. Secombes
Molecular and Functional Characterization of IL-15 in Rainbow Trout Oncorhynchus mykiss: A Potent Inducer of IFN-{gamma} Expression in Spleen Leukocytes
J. Immunol.,
August 1, 2007;
179(3):
1475 - 1488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. K. Mullarky, F. M. Szaba, L. W. Kummer, L. B. Wilhelm, M. A. Parent, L. L. Johnson, and S. T. Smiley
Gamma Interferon Suppresses Erythropoiesis via Interleukin-15
Infect. Immun.,
May 1, 2007;
75(5):
2630 - 2633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ennaciri, R. Ahmad, and J. Menezes
Interaction of monocytic cells with respiratory syncytial virus results in activation of NF-{kappa}B and PKC-{alpha}/{beta} leading to up-regulation of IL-15 gene expression
J. Leukoc. Biol.,
March 1, 2007;
81(3):
625 - 631.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Rodriguez, B. P. Arulanandam, V. L. Hodara, H. M. McClure, E. K. Cobb, M. T. Salas, R. White, and K. K. Murthy
Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees
J. Gen. Virol.,
February 1, 2007;
88(2):
641 - 651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Caccamo, S. Meraviglia, C. La Mendola, G. Guggino, F. Dieli, and A. Salerno
Phenotypical and Functional Analysis of Memory and Effector Human CD8 T Cells Specific for Mycobacterial Antigens
J. Immunol.,
August 1, 2006;
177(3):
1780 - 1785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Di Sabatino, R Ciccocioppo, F Cupelli, B Cinque, D Millimaggi, M M Clarkson, M Paulli, M G Cifone, and G R Corazza
Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease
Gut,
April 1, 2006;
55(4):
469 - 477.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Amlong, D. T. Nardelli, S. H. Peterson, T. F. Warner, S. M. Callister, and R. F. Schell
Anti-Interleukin-15 Prevents Arthritis in Borrelia-Vaccinated and -Infected Mice
Clin. Vaccine Immunol.,
February 1, 2006;
13(2):
289 - 296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Baranda, H. de la Fuente, E. Layseca-Espinosa, D. Portales-Perez, P. Nino-Moreno, G. Valencia-Pacheco, C. Abud-Mendoza, J. Alcocer-Varela, and R. Gonzalez-Amaro
IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus
Rheumatology,
December 1, 2005;
44(12):
1507 - 1513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Sparmann, A. Glass, P. Brock, R. Jaster, D. Koczan, H.-J. Thiesen, S. Liebe, and J. Emmrich
Inhibition of lymphocyte apoptosis by pancreatic stellate cells: impact of interleukin-15
Am J Physiol Gastrointest Liver Physiol,
November 1, 2005;
289(5):
G842 - G851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Giron-Michel, M. Giuliani, M. Fogli, D. Brouty-Boye, S. Ferrini, F. Baychelier, P. Eid, C. Lebousse-Kerdiles, D. Durali, R. Biassoni, et al.
Membrane-bound and soluble IL-15/IL-15R{alpha} complexes display differential signaling and functions on human hematopoietic progenitors
Blood,
October 1, 2005;
106(7):
2302 - 2310.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Imai, S. Iwamoto, and D. Campana
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
Blood,
July 1, 2005;
106(1):
376 - 383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Dubois, T. A. Waldmann, and J. R. Muller
Survival adjustment of mature dendritic cells by IL-15
PNAS,
June 14, 2005;
102(24):
8662 - 8667.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ing, P. Gros, and M. M. Stevenson
Interleukin-15 Enhances Innate and Adaptive Immune Responses to Blood-Stage Malaria Infection in Mice
Infect. Immun.,
May 1, 2005;
73(5):
3172 - 3177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wenxin, F. Jinxiang, W. Yong, L. Wenxiang, S. Wenbiao, and Z. Xueguang
Expression of membrane-bound IL-15 by bone marrow fibroblast-like stromal cells in aplastic anemia
Int. Immunol.,
April 1, 2005;
17(4):
429 - 437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. W. Blaser, S. Roychowdhury, D. J. Kim, N. R. Schwind, D. Bhatt, W. Yuan, D. F. Kusewitt, A. K. Ferketich, M. A. Caligiuri, and M. Guimond
Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease
Blood,
January 15, 2005;
105(2):
894 - 901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. McIntire, P. J. Morales, M. G. Petroff, M. Colonna, and J. S. Hunt
Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-{beta}1
J. Leukoc. Biol.,
December 1, 2004;
76(6):
1220 - 1228.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-S. Park, S.-O. Yoon, R. J. Armitage, and Y. S. Choi
Follicular Dendritic Cells Produce IL-15 That Enhances Germinal Center B Cell Proliferation in Membrane-Bound Form
J. Immunol.,
December 1, 2004;
173(11):
6676 - 6683.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. HAILU, T. VAN DER POLL, N. BERHE, and P. A. KAGER
ELEVATED PLASMA LEVELS OF INTERFERON (IFN)-{gamma}, IFN-{gamma} INDUCING CYTOKINES, AND IFN-{gamma} INDUCIBLE CXC CHEMOKINES IN VISCERAL LEISHMANIASIS
Am J Trop Med Hyg,
November 1, 2004;
71(5):
561 - 567.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ozawa, H. Tada, Y. Sugawara, A. Uehara, T. Sasano, H. Shimauchi, H. Takada, and S. Sugawara
Endogenous IL-15 Sustains Recruitment of IL-2R{beta} and Common {gamma} and IL-2-Mediated Chemokine Production in Normal and Inflamed Human Gingival Fibroblasts
J. Immunol.,
October 15, 2004;
173(8):
5180 - 5188.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Budagian, E. Bulanova, Z. Orinska, T. Pohl, E. C. Borden, R. Silverman, and S. Bulfone-Paus
Reverse Signaling through Membrane-bound Interleukin-15
J. Biol. Chem.,
October 1, 2004;
279(40):
42192 - 42201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Budagian, E. Bulanova, Z. Orinska, A. Ludwig, S. Rose-John, P. Saftig, E. C. Borden, and S. Bulfone-Paus
Natural Soluble Interleukin-15R{alpha} Is Generated by Cleavage That Involves the Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE/ADAM17)
J. Biol. Chem.,
September 24, 2004;
279(39):
40368 - 40375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. G. Neely, S. Epelman, L. L. Ma, P. Colarusso, C. J. Howlett, E. K. Amankwah, A. C. McIntyre, S. M. Robbins, and C. H. Mody
Monocyte Surface-Bound IL-15 Can Function as an Activating Receptor and Participate in Reverse Signaling
J. Immunol.,
April 1, 2004;
172(7):
4225 - 4234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Vankayalapati, P. Klucar, B. Wizel, S. E. Weis, B. Samten, H. Safi, H. Shams, and P. F. Barnes
NK Cells Regulate CD8+ T Cell Effector Function in Response to an Intracellular Pathogen
J. Immunol.,
January 1, 2004;
172(1):
130 - 137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Giron-Michel, A. Caignard, M. Fogli, D. Brouty-Boye, D. Briard, M. van Dijk, R. Meazza, S. Ferrini, C. Lebousse-Kerdiles, D. Clay, et al.
Differential STAT3, STAT5, and NF-{kappa}B activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules
Blood,
July 1, 2003;
102(1):
109 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bulanova, V. Budagian, Z. Orinska, H. Krause, R. Paus, and S. Bulfone-Paus
Mast Cells Express Novel Functional IL-15 Receptor {alpha} Isoforms
J. Immunol.,
May 15, 2003;
170(10):
5045 - 5055.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev.,
March 1, 2003;
55(1):
133 - 166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kurowska, W. Rudnicka, E. Kontny, I. Janicka, M. Chorazy, J. Kowalczewski, M. Ziolkowska, S. Ferrari-Lacraz, T. B. Strom, and W. Maslinski
Fibroblast-Like Synoviocytes from Rheumatoid Arthritis Patients Express Functional IL-15 Receptor Complex: Endogenous IL-15 in Autocrine Fashion Enhances Cell Proliferation and Expression of Bcl-xL and Bcl-2
J. Immunol.,
August 15, 2002;
169(4):
1760 - 1767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Briard, D. Brouty-Boye, B. Azzarone, and C. Jasmin
Fibroblasts from Human Spleen Regulate NK Cell Differentiation from Blood CD34+ Progenitors Via Cell Surface IL-15
J. Immunol.,
May 1, 2002;
168(9):
4326 - 4332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Y. Ong, Q. A. Hamid, J. B. Travers, I. Strickland, M. A. Kerithy, M. Boguniewicz, and D. Y. M. Leung
Decreased IL-15 May Contribute to Elevated IgE and Acute Inflammation in Atopic Dermatitis
J. Immunol.,
January 1, 2002;
168(1):
505 - 510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Schonbeck and P. Libby
CD40 Signaling and Plaque Instability
Circ. Res.,
December 7, 2001;
89(12):
1092 - 1103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bulanova, V. Budagian, T. Pohl, H. Krause, H. Durkop, R. Paus, and S. Bulfone-Paus
The IL-15R{alpha} Chain Signals Through Association with Syk in Human B Cells
J. Immunol.,
December 1, 2001;
167(11):
6292 - 6302.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. G. Neely, S. M. Robbins, E. K. Amankwah, S. Epelman, H. Wong, J. C. L. Spurrell, K. K. Jandu, W. Zhu, D. K. Fogg, C. B. Brown, et al.
Lipopolysaccharide-Stimulated or Granulocyte-Macrophage Colony-Stimulating Factor-Stimulated Monocytes Rapidly Express Biologically Active IL-15 on Their Cell Surface Independent of New Protein Synthesis
J. Immunol.,
November 1, 2001;
167(9):
5011 - 5017.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Mattei, G. Schiavoni, F. Belardelli, and D. F. Tough
IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation
J. Immunol.,
August 1, 2001;
167(3):
1179 - 1187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Fehniger and M. A. Caligiuri
Interleukin 15: biology and relevance to human disease
Blood,
January 1, 2001;
97(1):
14 - 32.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. AGOSTINI, M. FACCO, M. SIVIERO, D. CAROLLO, S. GALVAN, A. M. CATTELAN, R. ZAMBELLO, L. TRENTIN, and G. SEMENZATO
CXC Chemokines IP-10 and Mig Expression and Direct Migration of Pulmonary CD8+/CXCR3+ T Cells in the Lungs of Patients with HIV Infection and T-Cell Alveolitis
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1466 - 1473.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kitaya, J. Yasuda, I. Yagi, Y. Tada, S. Fushiki, and H. Honjo
IL-15 Expression at Human Endometrium and Decidua
Biol Reprod,
September 1, 2000;
63(3):
683 - 687.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. Ruckert, K. Asadullah, M. Seifert, V. M. Budagian, R. Arnold, C. Trombotto, R. Paus, and S. Bulfone-Paus
Inhibition of Keratinocyte Apoptosis by IL-15: A New Parameter in the Pathogenesis of Psoriasis?
J. Immunol.,
August 15, 2000;
165(4):
2240 - 2250.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Jourdan, J.-P. Vendrell, M.-F. Huguet, M. Segondy, J. Bousquet, J. Pene, and H. Yssel
Cytokines and Cell Surface Molecules Independently Induce CXCR4 Expression on CD4+ CCR7+ Human Memory T Cells
J. Immunol.,
July 15, 2000;
165(2):
716 - 724.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Gollob, J. W. Mier, K. Veenstra, D. F. McDermott, D. Clancy, M. Clancy, and M. B. Atkins
Phase I Trial of Twice-Weekly Intravenous Interleukin 12 in Patients with Metastatic Renal Cell Cancer or Malignant Melanoma: Ability to Maintain IFN-{{gamma}} Induction Is Associated with Clinical Response
Clin. Cancer Res.,
May 1, 2000;
6(5):
1678 - 1692.
[Abstract]
[Full Text]
|
|
|
| |
